Simulations Plus is a leading software development and consulting provider specializing in modeling and simulation solutions for pharmaceutical research, biotechnology, and regulatory compliance. The company creates specialized computer-based software programs—such as ADMET Predictor and GastroPlus—that allow scientists to simulate how chemical compounds and drugs behave within human and animal biological systems. These software applications help researchers predict pharmacokinetics, pharmacodynamics, toxicity levels, and drug-drug interactions long before physical laboratory testing or clinical human trials begin. By leveraging these advanced computational tools, pharmaceutical organizations can significantly reduce research and development costs, shorten time-to-market pipelines, and optimize formulation designs. In addition to software licensing, the firm offers expert scientific consulting services to assist clients with complex regulatory submissions and custom modeling projects tailored to modern drug discovery challenges.